Febuxostat
Back to searchMolecule Structure
Scientific Name
Febuxostat
Description of the Drug
Febuxostat is a xanthine oxidase inhibitor used for the management of chronic hyperuricemia in adults with gout who have an inadequate response or intolerance to allopurinol.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04854
http://www.drugbank.ca/drugs/DB04854
Brand Name(s)
Adenuric, Uloric
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Alkem Laboratories Ltd, Msn Laboratories Private Ltd, Alembic Pharmaceuticals Ltd, Takeda Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Xanthine dehydrogenase | SINGLE PROTEIN | INHIBITOR | CHEMBL1929 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL249339 | |
Human Metabolome Database | HMDB0252185 | |
DrugBank | DB04854 | |
PubChem: Thomson Pharma | 14899120 | |
PubChem | 134018 | |
Mcule | MCULE-6974079178 | |
LINCS | LSM-3064 | |
Nikkaji | J551.973J | |
PDBe | TEI | |
BindingDB | 50320491 | |
EPA CompTox Dashboard | DTXSID8048650 | |
DrugCentral | 1137 | |
Brenda | 92458 | |
ChemicalBook | CB4841564 | CB22508843 |
Guide to Pharmacology | 6817 | |
rxnorm | ULORIC | FEBUXOSTAT |
PubChem: Drugs of the Future | 12014717 | |
ChEBI | 31596 | |
ZINC | ZINC000000005423 |